Case study

Addressing an Evidentiary Gap With Real-World Prospective Studies

Learn how Xcenda helped one client address an evidence gap for a revolutionary new orphan drug.

Related resources

Newsletter

HTA Quarterly Summer 2026

Article

Rare diseases and orphan drugs: Assessing the PV implications

Article

AI-assisted quality assessment in HEOR: What works, what doesn’t, and how to apply GenAI responsibly